Hypomagnesaemia due to proton-pump inhibitor therapy: a clinical case series.
about
The association between the use of proton pump inhibitors and the risk of hypomagnesemia: a systematic review and meta-analysisProton pump inhibitors and hospitalization with hypomagnesemia: a population-based case-control studyProton pump inhibitor-associated hypomagnesemia: what do FDA data tell us?Perils and pitfalls of long-term effects of proton pump inhibitors.A Review of the Novel Application and Potential Adverse Effects of Proton Pump Inhibitors.Association of long-term proton pump inhibitor therapy with bone fractures and effects on absorption of calcium, vitamin B12, iron, and magnesiumAdverse effects of long-term proton pump inhibitor therapy.Omeprazole- and esomeprazole-associated hypomagnesaemia: data mining of the public version of the FDA Adverse Event Reporting SystemProton-pump inhibitor use is associated with lower urinary magnesium excretionHypomagnesemia Induced by Long-Term Treatment with Proton-Pump Inhibitors.The relationship between proton pump inhibitor use and serum magnesium concentration among hemodialysis patients: a cross-sectional study.Dietary Inulin Fibers Prevent Proton-Pump Inhibitor (PPI)-Induced Hypocalcemia in Mice.Out-of-hospital use of proton pump inhibitors and hypomagnesemia at hospital admission: a nested case-control studyHypomagnesaemia associated with long-term use of proton pump inhibitorsDoes long-term use of proton pump inhibitors cause hypomagnesaemia in Japanese outpatients?Use of Proton-Pump Inhibitors Predicts Heart Failure and Death in Patients with Coronary Artery Disease.A patient on long-term proton pump inhibitors develops sudden seizures and encephalopathy: an unusual presentation of hypomagnesaemia.Apical acidity decreases inhibitory effect of omeprazole on Mg(2+) absorption and claudin-7 and -12 expression in Caco-2 monolayers.Proton pump inhibitors use in hemodialysis patients and serum magnesium levelsProton pump inhibitor associated hypomagnasaemia - a cause for concern?Effects of proton pump inhibitors and electrolyte disturbances on arrhythmias.Proton pump inhibitor use is not associated with cardiac arrhythmia in critically ill patientsHow should hypomagnesaemia be investigated and treated?Prescribing proton pump inhibitors: is it time to pause and rethink?Systematic review: hypomagnesaemia induced by proton pump inhibition.Efficacy and safety of proton pump inhibitors in the management of pediatric gastroesophageal reflux disease.Hypomagnesemia and proton-pump inhibitors.Contemporary view of the clinical relevance of magnesium homeostasis.Hypomagnesemia in the intensive care unit: Choosing your gastrointestinal prophylaxis, a case report and review of the literature.Magnesium Deficiency and Proton-Pump Inhibitor Use: A Clinical Review.Proton pump inhibitor-induced hypomagnesaemia and hypocalcaemia: case review.The role of magnesium sulfate in the intensive care unit.Symptomatic hypomagnesemia and proton pump inhibitorsProton-pump inhibitors: understanding the complications and risks.Proton pump inhibitor-induced hypomagnesemia: A new challenge.Changes in serum magnesium concentration after use of a proton pump inhibitor in patients undergoing percutaneous coronary intervention.Omeprazole enhances the colonic expression of the Mg(2+) transporter TRPM6.The association of proton pump inhibitors and hypomagnesemia in the community setting.Proton-pump inhibitor use is associated with low serum magnesium concentrations.An electrocardiograph should be examined in patients with a hypersensitive esophagus before a trial of citalopram.
P2860
Q21090577-59C814BC-C917-480C-BEEF-BCBE14076112Q28543390-1ABA984D-A7C2-4260-874C-9A60B9DF2025Q30620638-07A79997-2B2F-40D0-99DE-D44E3B86544AQ33409626-5509051C-B20A-49A5-9B96-311EBF541556Q33441225-8642FA08-E42C-458B-A4DF-4E80D17F7748Q34140914-B398F866-0AD6-4658-9AD9-73CC79D67881Q34167899-D694E238-5437-4DCE-BC11-BBF3346523F1Q34320987-9A09F197-F903-4DF0-843A-A8DA21AC2216Q35038136-67F09489-B6F9-44CE-B1A7-FD35FBE37AA1Q35614268-02324D87-D0EA-4571-BAB9-693C7DE2BE99Q35744487-7A7880C2-2770-47CB-AA2F-216A3ECCD758Q35784892-D7BB1320-D618-466C-84EB-70848F37135EQ35899886-15E6763F-1195-4B05-B477-744F44BE2068Q35923371-3BBA4AA6-F7AE-491B-A247-43841C8A8462Q35943358-7EE5B0CA-2465-4DE2-BD76-3D9E6208437DQ36254177-8F748AD1-B770-40B1-BF77-F9A17FAA4BF4Q36424604-D5BCAAF7-A5DE-4A94-847C-971A32EBA18AQ36431083-F4C612E9-417D-4FE5-892C-BA3D08C0375EQ36493276-41E9BA6B-98DC-4E58-AADD-5771A77494D0Q36706785-99902BCF-8D24-4FA6-98CC-CCE9FF28F01EQ36980605-74EFDD7A-5AEC-47F8-9E08-98937C485DD5Q37013934-67DE5AA0-1D99-4180-ADB8-8A8DCF6AEF8FQ37875204-4CECD5F6-EC8C-471A-8E92-EA8712A4CC2AQ37987204-E52D88BA-B9A9-4314-991D-27B77A1C2756Q38023882-BC0C9648-DAE8-4094-8E56-52E1D26A1095Q38109860-B3954146-EADE-4530-8111-9AEC00CD3A8DQ38117650-419205AB-2678-4D1C-8152-0A1FF4BF417EQ38176746-8A2D923E-B139-428B-AE58-4C8345BFEA11Q38237373-6D291653-BEA9-49BC-8A0D-58E44F0535D1Q38638067-9C95151F-3C09-4FE8-BB88-1EE8B892F907Q39080559-5537EF36-C3F0-433A-B5D5-1E79007D6EBEQ39427028-141D0B15-3C92-4937-A6F6-2A3517A0FAB4Q41887409-0396B6B0-4D32-4E26-9605-2BECD68BCC82Q41996131-9B232703-AE6B-4BF5-B637-2585C3D89402Q42969618-15DDDD0B-76EA-4376-92A6-E7198FF7F204Q43249963-CC738B52-DFF6-47C8-8A28-F523433D1FC2Q43457054-D13A92FA-0631-4296-8327-6D269BD74EB6Q44104361-3DE0F6CD-33B3-43FC-9425-897327803304Q44522863-A58F0245-F3AA-4217-8EE6-A77AAE41F927Q44892226-63661441-1FA3-4306-A081-EA18C127107A
P2860
Hypomagnesaemia due to proton-pump inhibitor therapy: a clinical case series.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 April 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hypomagnesaemia due to proton-pump inhibitor therapy: a clinical case series.
@en
Hypomagnesaemia due to proton-pump inhibitor therapy: a clinical case series.
@nl
type
label
Hypomagnesaemia due to proton-pump inhibitor therapy: a clinical case series.
@en
Hypomagnesaemia due to proton-pump inhibitor therapy: a clinical case series.
@nl
prefLabel
Hypomagnesaemia due to proton-pump inhibitor therapy: a clinical case series.
@en
Hypomagnesaemia due to proton-pump inhibitor therapy: a clinical case series.
@nl
P356
P1476
Hypomagnesaemia due to proton-pump inhibitor therapy: a clinical case series.
@en
P2093
J D Mackay
P T Bladon
P304
P356
10.1093/QJMED/HCQ021
P407
P577
2010-04-08T00:00:00Z